Table 2 Comparison of clinical data between mild to moderate RLS patient group and (extremely) severe RLS patient group.

From: The association between vitamin D and restless legs syndrome following acute ischemic stroke

 

Mild to moderate RLS group (N= 34)

(Extremely) severe RLS group (N=19)

T/X2

P

No. of cases (n, %)

34(64.15)

19(35.85)

  

Age (years) mean ± SD

59.77±11.51

65.68±12.95

-1.716

0.092

Female, n (%)

12(35.29)

11(57.89)

2.535

0.111

Smoking status, n (%)

16(47.06)

3(15.79)

5.182

0.023

Alcohol consumption, n (%)

10(29.41)

3(15.79)

0.597

0.440

Hypertension, n (%)

21(61.76)

12(63.16)

0.010

0.920

Diabetes, n (%)

10(29.41)

6(31.58)

0.027

0.869

BMI [kg/m2,(\(\rm{\bar{X}}\)±S)]

25.06±5.49

25.73±4.26

-0.499

0.62

Triglyceride [mmol/L, (\(\rm{\bar{X}}\)±S)]

1.99±1.22

2.23±2.25

-0.500

0.619

Cholesterol[mmol/L, (\(\rm{\bar{X}}\)±S)]

4.52±1.20

4.81±1.60

-0.753

0.455

HDL-C [mmol/L, (\(\rm{\bar{X}}\)±S)]

1.11±0.24

1.25±0.74

-1.028

0.309

LDL-C [mmol/L, (\(\rm{\bar{X}}\)±S)]

2.56±0.78

2.70±1.02

-0.570

0.571

Glucose [mmol/L, (\(\rm{\bar{X}}\)±S)]

6.66±2.92

7.21±2.43

-0.700

0.487

Hemoglobin A1c [%, (\(\rm{\bar{X}}\)±S)]

7.04±1.96

7.11±1.61

-0.143

0.887

HCY [µmol/L, (\(\rm{\bar{X}}\)±S)]

19.08±8.33

18.09±12.61

-0.050

0.961

25-(OH) D [ng/mL, (\(\rm{\bar{X}}\)±S)]

15.29±4.04

8.95±2.41

6.227

<0.001